Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi
<p>Abstract</p> <p>Background</p> <p>Malaria is the leading cause of morbidity and mortality in post-conflict Burundi. To counter the increasing challenge of anti-malarial drug resistance and improve highly effective treatment Burundi adopted artesunate-amodiaquine (AS-...
Main Authors: | Dismas Baza, Karikari Patrick E, Boakye Isaac, Blay-Nguah Samuel, Diap Graciela, Amuasi John H, Karenzo Jeanne, Nsabiyumva Lievin, Louie Karly S, Kiechel Jean-René |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-02-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/10/1/34 |
Similar Items
-
Access to artemisinin-combination therapy (ACT) and other anti-malarials: national policy and markets in Sierra Leone.
by: John H Amuasi, et al.
Published: (2012-01-01) -
POPULATION PHARMACOKINETICS OF ARTESUNATE AND AMODIAQUINE IN AFRICAN CHILDREN
by: Stepniewska, K, et al.
Published: (2008) -
Comparison of the efficacy of artesunate-amodiaquine with quinine ... clindamycin for treatment of uncomplicated falciparum malaria in children
by: Purnama Fitri, et al.
Published: (2009-04-01) -
Population pharmacokinetics of artesunate and amodiaquine in African children.
by: Stepniewska, K, et al.
Published: (2009) -
Population pharmacokinetics of artesunate and amodiaquine in African children
by: Ouedraogo Alphonse, et al.
Published: (2009-08-01)